Chimeric Antigen Receptor News and Research

RSS
Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy

Stem cell transplants offer long-term benefits for pediatric cancer patients receiving immunotherapy

First cell-based gene therapy approved by the FDA for treating multiple myeloma

First cell-based gene therapy approved by the FDA for treating multiple myeloma

Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy

Moffitt researchers use mathematical modeling to help explain outcomes of CAR T-cell therapy

Study explores how CAR T immunotherapy could be used to treat solid tumors

Study explores how CAR T immunotherapy could be used to treat solid tumors

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

CAR T-cell therapy triples expected length of remission for relapsed multiple myeloma patients

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Experimental safety switch reduces severity of CAR-T immunotherapy-related side effects

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

Innovative cancer treatment effective in combating fungal infection in vitro and in mice

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

ACGT awards $500,000 to advance immunotherapy approach for treating solid tumors

AI-based 3D holographic microscopy found to be better at analyzing cancer immunotherapy​

AI-based 3D holographic microscopy found to be better at analyzing cancer immunotherapy​

Understanding the dynamics of brain blood flow could hold key for treating neurologic conditions

Understanding the dynamics of brain blood flow could hold key for treating neurologic conditions

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

Clinical trial shows five-year outcomes of CAR T-cell therapy for non-Hodgkin lymphomas

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

FDA approves cell-based gene therapy to treat adults with relapsed or refractory large-B-cell lymphoma

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Immune dysregulation can affect the efficacy of CAR T therapy in some lymphoma patients

Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

Modified version of CAR T-cell therapy shows promise in targeting neuroblastoma

Eliminating key gene could revive exhausted immune cells to battle solid tumors

Eliminating key gene could revive exhausted immune cells to battle solid tumors

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Modified natural killer cells show neutralizing and multivalent potential against SARS-CoV-2 in vitro

Study investigates effect of anti-CD45 RIT lymphodepletion on immune cell types

Study investigates effect of anti-CD45 RIT lymphodepletion on immune cell types

MDC researchers develop a potent weapon against lymphomas

MDC researchers develop a potent weapon against lymphomas

NCCN publishes new informational resources on health and wellness for cancer survivors

NCCN publishes new informational resources on health and wellness for cancer survivors

Researchers discover protein crucial to T cell metabolism and anti-tumor immune response

Researchers discover protein crucial to T cell metabolism and anti-tumor immune response